Clinical Trials, page-6

This is how it is all the time wen you dont hold a share.
ATH :ASX
Principal Activity: Commercialism research into Parkinsonian movement disorders, Alzheimer's disease, Huntington disease and other neurodegenerative disorders.

SP jumped from 0.017 to 0.30 an increase of 1700%+ today
why ??
The company announced yesterday late eve --->>>
ATH is pleased to announce that it has received guidance from
the US Food and Drug Administration (FDA) in relation to the development pathway for ATH434
(previously PBT434), the company’s lead compound for the treatment of Multiple System Atrophy (MSA),
a Parkinsonian disorder.

I mean WTF ??? a guidance from an US company push the price forward by 1700%+ in 30 min today.

Where we the PAA holders are at ???

one trying to cure parkinson and one trying to cure cancer and other elements.

F*** my luck